pharmasol, a specialist software program and full-service options supplier that works to optimize pharmacovigilance processes, has formally merged with PharmaLex Group, a specialised companies supply for the pharma, biotech and medtech industries.
The knowledge expertise firm gives pharmacovigilance and end-to-end enterprise assist information to the expanded group, extending the answer footprint of PharmaLex’s Expertise-Enabled Good Providers (TESS) division. The corporate permits organizations to implement, automate and optimize regulatory duties, together with SUSAR (Suspected Sudden Critical Opposed Reactions) distribution through its industry-leading psiXchange platform.
“This strategic partnership with PharmaLex is a key milestone in our mission to create a dominant market place and improve our complete answer portfolio providing to our shoppers,” notes pharmasol CEO Torsten Adam. “This landmark alliance empowers each organizations to supply higher depth and breadth of service within the fast-growing and extremely aggressive space of pharmacovigilance.”